North China Pharmaceutical Company.,Ltd. Posted 19.2 Million Yuan Net Profit in First Quarter of 2022

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 19.2 million yuan in the first quarter of 2022, reversing a net loss of 53.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 2.5 billion yuan in revenue, down 6.3% year-on-year.

At the end of the reporting period, it had 25.2 billion yuan in total assets and 18.1 billion yuan in total liabilities, with a liability-to-asset ratio of 72%.